BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24650367)

  • 21. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer.
    Chang YW; Chen MW; Chiu CF; Hong CC; Cheng CC; Hsiao M; Chen CA; Wei LH; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S687-95. PubMed ID: 25047463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
    Dutta S; Wang FQ; Wu HS; Mukherjee TJ; Fishman DA
    Gynecol Oncol; 2011 Oct; 123(1):129-37. PubMed ID: 21782227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of galectin-3 causes a decrease in uPAR levels and inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells.
    Zheng D; Hu Z; He F; Gao C; Xu L; Zou H; Wu Z; Jiang X; Wang J
    Oncol Rep; 2014 Jul; 32(1):411-8. PubMed ID: 24807674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway.
    Kumar B; Chile SA; Ray KB; Reddy GE; Addepalli MK; Kumar AS; Ramana V; Rajagopal V
    Angiogenesis; 2011 Sep; 14(3):371-80. PubMed ID: 21698469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of JAK1/STAT3 in the cervical carcinoma cell line C33A.
    Yan CM; Zhao YL; Cai HY; Miao GY; Ma W
    Oncol Rep; 2015 Apr; 33(4):1737-44. PubMed ID: 25634668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose radiation-induced epithelial-mesenchymal transition through NF-κB in cervical cancer cells.
    Yan S; Wang Y; Yang Q; Li X; Kong X; Zhang N; Yuan C; Yang N; Kong B
    Int J Oncol; 2013 May; 42(5):1801-6. PubMed ID: 23483258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma.
    Kim MK; Sung CO; Do IG; Jeon HK; Song TJ; Park HS; Lee YY; Kim BG; Lee JW; Bae DS
    Int J Clin Oncol; 2011 Aug; 16(4):352-8. PubMed ID: 21327452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells.
    Tang X; Zhang Q; Nishitani J; Brown J; Shi S; Le AD
    Clin Cancer Res; 2007 May; 13(9):2568-76. PubMed ID: 17473185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
    Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation.
    Zhang Y; Xia P; Zhang W; Yan M; Xiong X; Yu W; Song E
    Hum Pathol; 2017 Jul; 65():113-122. PubMed ID: 28511963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.
    Mourad-Zeidan AA; Melnikova VO; Wang H; Raz A; Bar-Eli M
    Am J Pathol; 2008 Dec; 173(6):1839-52. PubMed ID: 18988806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival.
    Ikemori RY; Machado CM; Furuzawa KM; Nonogaki S; Osinaga E; Umezawa K; de Carvalho MA; Verinaud L; Chammas R
    PLoS One; 2014; 9(11):e111592. PubMed ID: 25369297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronan-binding protein 1 (HABP1/p32/gC1qR) induces melanoma cell migration and tumor growth by NF-kappa B dependent MMP-2 activation through integrin α(v)β(3) interaction.
    Prakash M; Kale S; Ghosh I; Kundu GC; Datta K
    Cell Signal; 2011 Oct; 23(10):1563-77. PubMed ID: 21627988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
    Zhu H; Yun F; Shi X; Wang D
    Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway.
    Tong Q; Zheng L; Lin L; Li B; Wang D; Huang C; Li D
    Respir Res; 2006 Mar; 7(1):37. PubMed ID: 16512910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RARα mediates all-trans-retinoic acid-induced VEGF-C, VEGF-D, and VEGFR3 expression in lung cancer cells.
    Kalitin NN; Karamysheva AF
    Cell Biol Int; 2016 Apr; 40(4):456-64. PubMed ID: 26818829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor is implicated in early invasion in cervical cancer.
    Kodama J; Seki N; Tokumo K; Hongo A; Miyagi Y; Yoshinouchi M; Okuda H; Kudo T
    Eur J Cancer; 1999 Mar; 35(3):485-9. PubMed ID: 10448304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.